Cargando…

Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up

BACKGROUND: We need to better understand how the use of different substances and psychiatric comorbidity influence premature death generally and cause-specific death by overdose, intoxication and somatic disorders in people with substance use disorders. METHOD: A cohort of 1405 patients consecutivel...

Descripción completa

Detalles Bibliográficos
Autores principales: Fridell, Mats, Bäckström, Martin, Hesse, Morten, Krantz, Peter, Perrin, Sean, Nyhlén, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518448/
https://www.ncbi.nlm.nih.gov/pubmed/31092225
http://dx.doi.org/10.1186/s12888-019-2098-3
_version_ 1783418451126124544
author Fridell, Mats
Bäckström, Martin
Hesse, Morten
Krantz, Peter
Perrin, Sean
Nyhlén, Anna
author_facet Fridell, Mats
Bäckström, Martin
Hesse, Morten
Krantz, Peter
Perrin, Sean
Nyhlén, Anna
author_sort Fridell, Mats
collection PubMed
description BACKGROUND: We need to better understand how the use of different substances and psychiatric comorbidity influence premature death generally and cause-specific death by overdose, intoxication and somatic disorders in people with substance use disorders. METHOD: A cohort of 1405 patients consecutively admitted to a Swedish detoxification unit for substance use disorders in 1970–1995 was followed-up for 42 years. Substances were identified by toxicological analyses. Mortality figures were obtained from a national registry. Causes of death were diagnosed by forensic autopsy in 594 patients deceased by 2012. Predictions were calculated by competing risks analysis. RESULTS: Forty-two per cent of the cohort died during follow-up; more men than women (46.3% vs 30.4%). The standardised mortality ratio (SMR) was calculated as the ratio of observed deaths in males and females in specific age groups in the cohort versus expected deaths in corresponding groups in the general population. SMR was 5.68 for men (CI 95%; 5.04–6.11) and 4.98 (CI 95%; 4.08–5.88) for women. The crude mortality rate (number of deaths divided by number of person observation years) was 2.28% for men and 1.87% for women. Opiates predicted increased risk of premature death while amphetamine and cannabis predicted lower risk. Comorbid psychiatric disorders were identified in 378 cases and personality disorders in 763 cases. Primary psychoses or mood/depression and anxiety disorders predicted a higher risk of premature mortality. Death by overdose was predicted by male gender, younger age at admission to substance treatment, opiate use, and comorbid depression and anxiety syndromes. Cannabis and amphetamine use predicted a lower risk of overdose. Death by intoxication was predicted by male gender, use of sedatives/hypnotics or alcohol/mixed substances, primary psychoses and depression/anxiety syndromes. Premature death by somatic disorder was predicted by male gender and alcohol/mixed abuse. CONCLUSION: Psychiatric comorbid disorders were important risk factors for premature drug-related death. Early identification of these factors may be life-saving in the treatment of patients with substance use disorders.
format Online
Article
Text
id pubmed-6518448
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65184482019-05-21 Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up Fridell, Mats Bäckström, Martin Hesse, Morten Krantz, Peter Perrin, Sean Nyhlén, Anna BMC Psychiatry Research Article BACKGROUND: We need to better understand how the use of different substances and psychiatric comorbidity influence premature death generally and cause-specific death by overdose, intoxication and somatic disorders in people with substance use disorders. METHOD: A cohort of 1405 patients consecutively admitted to a Swedish detoxification unit for substance use disorders in 1970–1995 was followed-up for 42 years. Substances were identified by toxicological analyses. Mortality figures were obtained from a national registry. Causes of death were diagnosed by forensic autopsy in 594 patients deceased by 2012. Predictions were calculated by competing risks analysis. RESULTS: Forty-two per cent of the cohort died during follow-up; more men than women (46.3% vs 30.4%). The standardised mortality ratio (SMR) was calculated as the ratio of observed deaths in males and females in specific age groups in the cohort versus expected deaths in corresponding groups in the general population. SMR was 5.68 for men (CI 95%; 5.04–6.11) and 4.98 (CI 95%; 4.08–5.88) for women. The crude mortality rate (number of deaths divided by number of person observation years) was 2.28% for men and 1.87% for women. Opiates predicted increased risk of premature death while amphetamine and cannabis predicted lower risk. Comorbid psychiatric disorders were identified in 378 cases and personality disorders in 763 cases. Primary psychoses or mood/depression and anxiety disorders predicted a higher risk of premature mortality. Death by overdose was predicted by male gender, younger age at admission to substance treatment, opiate use, and comorbid depression and anxiety syndromes. Cannabis and amphetamine use predicted a lower risk of overdose. Death by intoxication was predicted by male gender, use of sedatives/hypnotics or alcohol/mixed substances, primary psychoses and depression/anxiety syndromes. Premature death by somatic disorder was predicted by male gender and alcohol/mixed abuse. CONCLUSION: Psychiatric comorbid disorders were important risk factors for premature drug-related death. Early identification of these factors may be life-saving in the treatment of patients with substance use disorders. BioMed Central 2019-05-15 /pmc/articles/PMC6518448/ /pubmed/31092225 http://dx.doi.org/10.1186/s12888-019-2098-3 Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Fridell, Mats
Bäckström, Martin
Hesse, Morten
Krantz, Peter
Perrin, Sean
Nyhlén, Anna
Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up
title Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up
title_full Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up
title_fullStr Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up
title_full_unstemmed Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up
title_short Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up
title_sort prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518448/
https://www.ncbi.nlm.nih.gov/pubmed/31092225
http://dx.doi.org/10.1186/s12888-019-2098-3
work_keys_str_mv AT fridellmats predictionofpsychiatriccomorbidityonprematuredeathinacohortofpatientswithsubstanceusedisordersa42yearfollowup
AT backstrommartin predictionofpsychiatriccomorbidityonprematuredeathinacohortofpatientswithsubstanceusedisordersa42yearfollowup
AT hessemorten predictionofpsychiatriccomorbidityonprematuredeathinacohortofpatientswithsubstanceusedisordersa42yearfollowup
AT krantzpeter predictionofpsychiatriccomorbidityonprematuredeathinacohortofpatientswithsubstanceusedisordersa42yearfollowup
AT perrinsean predictionofpsychiatriccomorbidityonprematuredeathinacohortofpatientswithsubstanceusedisordersa42yearfollowup
AT nyhlenanna predictionofpsychiatriccomorbidityonprematuredeathinacohortofpatientswithsubstanceusedisordersa42yearfollowup